U-Chart Analysis:KAKEN PHARMACEUTICAL CO.,LTD.:4521

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KAKEN PHARMACEUTICAL CO.,LTD. Go to web site 4521 Medicals 東証プライム March 1, 2000 1961.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KAKEN PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAKEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 50,625 59,561 61,025 63,706 59,722
Other Current AssetsHelp 56,349 50,342 49,588 49,956 48,614
Tangible Fixed AssetsHelp 25,355 25,498 25,734 25,020 25,518
Intangible Fixed AssetHelp 7,462 6,741 8,236 625 414
Investments and OthersHelp 31,832 24,186 20,598 24,025 23,607
Total AssetsHelp 171,623 166,328 165,181 163,332 157,875
Total Current LiabilitiesHelp 27,868 30,070 27,434 27,075 29,407
Total Long-term LiabilitiesHelp 0 0 0 0 0
Shareholder's EquityHelp 143,755 136,258 137,747 136,257 128,468
Total LiabilitiesHelp 171,623 166,328 165,181 163,332 157,875

KAKEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAKEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 72,044 72,984 76,034 74,979 89,232
Total Sales 72,044 72,984 76,034 74,979 89,232
Cost of SalesHelp 33,505 33,428 34,458 34,073 38,753
Other Costs and RevenueHelp 30,513 34,116 32,027 27,501 31,109
Total CostsHelp 64,018 67,544 66,485 61,574 69,862
Net RevenueHelp 38,539 39,556 41,576 40,906 50,479
Earnings Before TaxHelp 9,796 6,817 13,885 18,657 26,592
Net IncomeHelp 8,026 5,440 9,549 13,405 19,370
Net Income 8,026 5,440 9,549 13,405 19,370

KAKEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAKEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 KAKEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 2,577 9,253 13,337 14,379 27,467
Investing Cash Flow(ICF)Help -5,854 -2,627 -7,888 -1,644 -2,528
Financing Cash FlowHelp -5,658 -6,990 -8,129 -8,752 -10,173
Exchange Difference of Cash and Cash EquivalentsHelp 0 0 0 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -8,935 -364 -2,680 3,983 14,766

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KAKEN PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

DAIICHI SANKYO COMPANY, LIMITED
MIKASA SEIYAKU CO.,LTD.
Perseus Proteomics Inc.
Kringle Pharma,Inc.
HISAMITSU PHARMACEUTICAL CO.,INC.
EIKEN CHEMICAL CO.,LTD.
TOWA PHARMACEUTICAL CO.,LTD.
Oncolys BioPharma Inc.
ECI,Inc.
Renascience Inc.